[ Price : $8.95]
Federal Register notice: FDA makes available a final guidance entitled Application of Human Factors Engineering (HFE) Principles f...[ Price : $8.95]
U.S. Senators Joe Manchin (D-WV) and Mike Braun (R-IN) reintroduce their bipartisan FDA Review of Efficacy EERW Double-Blinds (FRE...[ Price : $8.95]
The House Energy and Commerce Committee announces a 9/14 legislative hearing to discuss legislative proposals on preventing generi...[ Price : $8.95]
FDA posts a guidance entitled Institutional Review Board (IRB) Review of Individual Patient Expanded Access Submissions for Invest...[ Price : $8.95]
FDA requests updated chemistry, manufacturing and controls information on Genentechs subcutaneous formulation of lung cancer drug ...[ Price : $8.95]
In what is a likely sign of increasing interest on Capitol Hill, the Government Accountability Office releases a new report examin...[ Price : $8.95]
Federal Register notice: FDA announces an 11/17 Pulmonary-Allergy Drugs Advisory Committee to review a Merck NDA for gefapixant or...[ Price : $8.95]
Federal Register notice: FDA plans an 11/9 public meeting entitled Endpoints and Trial Designs to Advance Drug Development in Kidn...